BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Iverson Genetic Diagnostics Selects UPS to Provide Shipping Services for Medicare Approved WARFARIN Study Addressing Bleeding


9/29/2010 9:00:28 AM

BOTHELL, Wash.--(BUSINESS WIRE)--Iverson Genetic Diagnostics today announced the selection of UPS (NYSE:UPS) to provide shipping services for its upcoming WARFARIN Study. In late June of 2010, Iverson Genetic Diagnostics, Inc. received approval from the Centers for Medicare & Medicaid Services (CMS) to conduct a two-year study that will assess the impact of genetic information on the occurrence of adverse bleeding events when determining the initial dose of warfarin compared to adverse events for those not using genetics in dose determination. The randomized and blinded, multi-center study will involve more than 7,000 patients at over 50 hospital sites nationwide.

Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->